IDDI INTERNATIONAL DRUG DEVELOPMENT INSTITUTE Trademark
Trademark Overview
On Monday, May 13, 2002, a trademark application was filed for IDDI INTERNATIONAL DRUG DEVELOPMENT INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the IDDI INTERNATIONAL DRUG DEVELOPMENT INSTITUTE trademark a serial number of 78128339. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 4, 2011. This trademark is owned by International Drug Development Institute. The IDDI INTERNATIONAL DRUG DEVELOPMENT INSTITUTE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and consultation services in the field of clinical trials for drug development, including the areas of clinical operations, data management, biostatistics, clinical systems, clinical development strategies, experimental design, clinical trial methodology, clinical research in oncology and other therapeutic areas, and epistemology
General Information
| Serial Number | 78128339 |
| Word Mark | IDDI INTERNATIONAL DRUG DEVELOPMENT INSTITUTE |
| Filing Date | Monday, May 13, 2002 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 4, 2011 |
| Registration Number | 2869120 |
| Registration Date | Tuesday, August 3, 2004 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 11, 2004 |
Trademark Statements
| Disclaimer with Predetermined Text | "INTERNATIONAL DRUG DEVELOPMENT INSTITUTE" |
| Description of Mark | The mark consists of the letters and name as shown which may be displayed in black and white or with Navvy letters for the symbol, red letters for the full spelling and the ball in the center colored red. |
| Goods and Services | Research and consultation services in the field of clinical trials for drug development, including the areas of clinical operations, data management, biostatistics, clinical systems, clinical development strategies, experimental design, clinical trial methodology, clinical research in oncology and other therapeutic areas, and epistemology |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 4, 2011 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, November 8, 2000 |
| First Use In Commerce Date | Wednesday, November 8, 2000 |
Trademark Owner History
| Party Name | International Drug Development Institute |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | International Drug Development Institute |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | International Drug Development Institute |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Friday, March 4, 2011 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, December 1, 2009 | CASE FILE IN TICRS |
| Tuesday, August 3, 2004 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 11, 2004 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 21, 2004 | NOTICE OF PUBLICATION |
| Tuesday, March 2, 2004 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, September 8, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 8, 2003 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 2, 2003 | FINAL REFUSAL E-MAILED |
| Wednesday, February 26, 2003 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 26, 2003 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 26, 2003 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 4, 2002 | NON-FINAL ACTION E-MAILED |
| Thursday, August 29, 2002 | ASSIGNED TO EXAMINER |
